These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3076787)

  • 21. A double-blind study of Inderex in the treatment of essential hypertension.
    Crowe PF; Finnegan OC; Russell CJ; Varma MP
    Br J Clin Pract; 1987 Oct; 41(10):967-70. PubMed ID: 3333146
    [No Abstract]   [Full Text] [Related]  

  • 22. [Penbutolol and propranolol in the treatment of hypertension. A double-blind comparative study in general practice].
    Astvad K; Krogh A; Sidenius J
    Ugeskr Laeger; 1984 Oct; 146(41):3104-6. PubMed ID: 6393504
    [No Abstract]   [Full Text] [Related]  

  • 23. Propranolol-hydrochlorothiazide combination in essential hypertension.
    Stevens JD; Mullane JF
    Clin Ther; 1982; 4(6):497-509. PubMed ID: 7046937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biochemical changes in hypertensive patients during a 1-year cross-over study of treatment with hydrochlorothiazide and propranolol].
    Bagatin J; Rumboldt Z; Polić S; Sardelić S; Ljutić D; Capkun V; Pivac N; Petrović P; Bojić L
    Lijec Vjesn; 1996; 118(1-2):11-6. PubMed ID: 8759414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mild or moderate arterial hypertension. Clinical, phonomechanocardiographic and echocardiographic evaluation of pindolol and propranolol].
    Sekeff JA; Bueno MS; Weitzel LH; Thevenard RS; Azevedo Ade C
    Arq Bras Cardiol; 1986 Apr; 46(4):251-4. PubMed ID: 3548665
    [No Abstract]   [Full Text] [Related]  

  • 26. Nicardipine and propranolol in the treatment of essential hypertension.
    Lessem JN; Barone EJ; Berl T; Detwiler J; Lewin AT; Lubash GD; Margolis R; McGowan RL; Ram CV; Vlachakis N
    Am J Hypertens; 1989 Mar; 2(3 Pt 1):146-53. PubMed ID: 2645914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Twice-daily nicardipine in the treatment of essential hypertension.
    Charlap S; Kimmel B; Laifer L; Weinberg P; Singer M; Lazar E; Saltzberg S; Dorsa F; Kafka K; Strom J
    J Clin Hypertens; 1986 Sep; 2(3):271-7. PubMed ID: 3537214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicentre study of cardioselective metoprolol (Lopresor) and non-selective propranolol in the management of mild to moderate hypertension.
    Browning RC; Ebbutt A; Russell JG; Mayhew SR
    Br J Clin Pract; 1981; 35(11-12):399-402. PubMed ID: 7306448
    [No Abstract]   [Full Text] [Related]  

  • 29. [Nicardipine in the treatment of Raynaud's phenomenon].
    Kahan A; Amor B; Menkès CJ
    Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):487-90. PubMed ID: 3303287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic effects of propranolol and hydroflumethiazide treatment in Kenyans with mild to moderate essential hypertension.
    Yonga GO; Ogola EN; Orinda DA
    East Afr Med J; 1993 Nov; 70(11):696-700. PubMed ID: 8033771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trial of nicardipine in treatment of mild to moderate hypertension.
    Yajnik VH; Vatsaraj DJ; Acharya HK; Yajnik NV
    J Assoc Physicians India; 1995 Jun; 43(6):401-3. PubMed ID: 8906946
    [No Abstract]   [Full Text] [Related]  

  • 32. Verapamil and beta-blockers in hypertension: a beneficial drug interaction?
    Dargie HJ
    Br J Clin Pract Suppl; 1985 Jun; 42():44-7. PubMed ID: 3929827
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of arterial hypertension with a new calcium antagonist: nicardipine].
    Bellet M; Loria Y; Lallemand A
    Cardiologia; 1987 May; 32(5):485-9. PubMed ID: 3304631
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension.
    Bagatin J; Sardelić S; Pivac N; Polić S; Ljutic D; Rakic D; Naranca M; Bojić L; Kovacić Z; Rumboldt Z
    Int J Clin Pharmacol Res; 1998; 18(2):73-8. PubMed ID: 9675624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-acting or conventional propanolol in hypertension?
    Woods JO
    Practitioner; 1979 Dec; 223(1338):834-7. PubMed ID: 396526
    [No Abstract]   [Full Text] [Related]  

  • 37. Sexual symptoms in hypertensive patients. A clinical trial of antihypertensive medications.
    Croog SH; Levine S; Sudilovsky A; Baume RM; Clive J
    Arch Intern Med; 1988 Apr; 148(4):788-94. PubMed ID: 3281619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double blind study with propranolol in the treatment of hypertension.
    De Tollenaere G
    Brux Med; 1973 Nov; Spec No(0):99-110. PubMed ID: 4609568
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of the effect of pindolol vs propranolol on the lipid profile in patients treated for hypertension.
    Samuel P; Chin B; Schoenfeld BH; Schaefer EJ; Gonasun LM
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):63S-64S. PubMed ID: 3326636
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
    Rakić D; Rumboldt Z; Bagatin J; Polić S
    Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.